Biocept News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

21.08.18	LCI Whacked On Contract Loss, CWBR Awaits Data, Busy Months Ahead For PLSE (RTTNews)
12.07.18	EOLS Makes Investors Smile, ACIU Up 72% In 4 Days, Busy Days Ahead For ABUS (RTTNews)
18.06.18	Published Case Report Demonstrates the Clinical Utility of Biocept's CTC Platform in the Management of Patients with Metastatic Breast Cancer (PR Newswire)
11.06.18	VWR, Part of Avantor, and Biocept Announce the Launch of CEE-Sure Blood Collection Tubes for cfDNA and CTCs (PR Newswire)
29.05.18	Biocept to Present at the 8th Annual LD Micro Invitational Conference on June 5 (PR Newswire)
15.05.18	Biocept Reports First Quarter 2018 Financial Results (PR Newswire)
08.05.18	Biocept to Release First Quarter 2018 Financial Results and Host Investor Conference Call on May 15, 2018 (PR Newswire)
07.05.18	SenesTech, Inc. to Report First Quarter Fiscal Year 2018 Financial Results on Monday, May 14, 2018 (PR Newswire)
01.05.18	Case Report in Journal of Thoracic Oncology Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for Patient Diagnosed with Non-Small Cell Lung Cancer (PR Newswire)
27.04.18	Published Case Study Demonstrates the Clinical Utility of Biocept's Liquid Biopsy Test for ALK Rearrangements (PR Newswire)
06.04.18	Biocept to Webcast Presentation at the 7th Annual MicroCap Conference (PR Newswire)
03.04.18	Biocept to Present at the 7th Annual MicroCap Conference (PR Newswire)
29.03.18	Biocept Obtains Patent for its Target Selector Molecular Biomarker Technology in China (PR Newswire)
28.03.18	Biocept Reports 2017 Fourth Quarter and Full Year Financial Results (PR Newswire)
28.03.18	Biocept and Thermo Fisher Scientific Enter into Technology and Commercial Collaboration (PR Newswire)
20.03.18	Biocept to Present Recent Advances in Biomarker Identification from Liquid Biopsies at GTCbio's 11th Biomarker Summit (PR Newswire)
15.03.18	Biocept's Target Selector Platform Featured in Two Poster Presentations at the 2018 American Association for Cancer Research Annual Meeting (PR Newswire)
12.03.18	Biocept to Release 2017 Fourth Quarter and Full Year Financial Results and Host Investor Conference Call on March 28, 2018 (PR Newswire)
06.03.18	Biocept to Present at the 30th Annual ROTH Conference (PR Newswire)
05.02.18	Biocept Receives Additional Patent Issuances in Three Major International Territories for its Target Selector Platform (PR Newswire)
30.01.18	Biocept Comments on Updated Consensus Medical Guidelines Recommending Liquid Biopsy for Profiling of Tumor Biomarkers to Assist with the Treatment of Patients with Lung Cancer (PR Newswire)
09.01.18	Biocept Study Shows Incorporation of Thermo Fisher QuantStudio 5 PCR Instrument into Target Selector Platform Improves Sensitivity and Specificity in Detection of Lung Cancer Biomarkers (PR Newswire)
04.01.18	Biocept Obtains Patent in Australia for its Molecular Biomarker Technology For the Detection of Cancer-Associated Mutations in Blood, Tissue, and Other Biological Sources (PR Newswire)
18.12.17	Biocept Signs In-Network Provider Agreement with Wellmark Blue Cross Blue Shield Expanding Coverage for its Target Selector Platform in Iowa and South Dakota (PR Newswire)
06.12.17	NVO Gets FDA Nod, GALT Down But Not Out, BIOC Gets A Boost, CUR Excited (RTTNews)
05.12.17	First U.S. Patent Issued for Biocept's Target Selector Oncogene Mutation Enrichment and Detection Liquid Biopsy ctDNA Platform (PR Newswire)
30.11.17	Edico Genome Launches DRAGEN Complete Suite On AWS Marketplace, Including Enhanced Second-Generation Germline And Somatic Pipelines (PR Newswire)
28.11.17	Biocept and UC San Diego Medical Center Announce Clinical Study Collaboration to Demonstrate Utility of Biocept's Liquid Biopsy Test in Immunotherapy (PR Newswire)
09.11.17	Biocept Reports Third Quarter 2017 Financial Results (PR Newswire)
02.11.17	Biocept to Release Third Quarter Financial Results and Host Investor Conference Call on November 9, 2017 (PR Newswire)
18.10.17	Biocept Launches Pathology Partnership Initiative Expanding Access of Proprietary Liquid Biopsy Testing to Community Pathologists and Hospitals (PR Newswire)
11.10.17	Renowned Lung Cancer Expert Fred R. Hirsch, M.D., Ph.D. Joins Biocept's Clinical Advisory Board (PR Newswire)
03.10.17	Biocept and Miraca Life Sciences Enter Into Marketing Agreement to Expand Target Selector Testing in the United States (PR Newswire)
05.09.17	Biocept Launches Liquid Biopsy Test for NRAS Mutations (PR Newswire)
28.08.17	Biocept to Present at the 6th Annual Gateway Conference on September 6, 2017 in San Francisco (PR Newswire)
17.08.17	Biocept and UT Southwestern Medical Center Announce Clinical Study to Profile and Monitor Non-Small Cell Lung Cancer Patients with ALK Rearrangements (PR Newswire)
14.08.17	Biocept Enters Into Exclusive Distribution Agreement with Global Laboratory Product Supplier VWR (PR Newswire)
11.08.17	Medical Laboratories Stocks on Investors' Radar -- DexCom, Novadaq Technologies, Biocept, and Exact Sciences (PR Newswire)
10.08.17	Biocept Reports Second Quarter 2017 Financial Results (PR Newswire)
10.08.17	Biocept Announces Private Placement of $2.2 Million of Common Stock with Ally Bridge LB Healthcare Master Fund (PR Newswire)
07.08.17	Biocept Executes Preferred Provider Agreement with Scripps Health Plan Expanding Patient Coverage for its Liquid Biopsy Platform (PR Newswire)
14.07.17	Biocept Expands Commercial Offering of Clinically Actionable Biomarker Assays with Launch of Liquid Biopsy Test for Progesterone Receptor Detection (PR Newswire)
26.06.17	Biocept Added to the Russell Microcap Index (PR Newswire)
21.06.17	Biocept and MediNcrease Health Plans Announce Provider Agreement Expanding Access to Liquid Biopsy Testing (PR Newswire)
24.05.17	Research Reports Coverage on Healthcare Stocks -- Biocept, Varian Medical Systems, Hill-Rom, and Tivity Health (PR Newswire)
22.05.17	Biocept Awarded U.S. Patent with Broad Claims for Antibody Capture of Targets of Interest on Any Solid Surface Including CTCs and Other Materials Shed by Solid Tumors into Blood (PR Newswire)
18.05.17	Biocept's Target Selector Platform Featured in Three Clinical Abstracts at the 2017 American Society of Clinical Oncology Annual Meeting Where Company Plans to Launch New Marketing Campaign (PR Newswire)
10.05.17	The Addario Lung Cancer Medical Institute and Biocept Announce Collaboration and Initiation of Landmark ALCMI-009 Liquid Biopsy Clinical Trial in Lung Cancer (PR Newswire)
10.05.17	Gainers & Losers Of May 9: VRX, ENDP, PTLA, SCYX, NXTM... (RTTNews)
09.05.17	Valeant Announces First Quarter 2017 Results And Raises Full Year Adjusted EBITDA Guidance Range (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Swisscom	527.00	2.33 %	K V
Holcim	95.34	1.21 %	K V
UBS Group	30.42	0.86 %	K V
Roche Hldg G	289.00	0.45 %	K V
Swiss Re	141.65	0.35 %	K V
Givaudan	3’850.00	-1.48 %	K V
Lonza Grp	603.80	-1.50 %	K V
Alcon	82.30	-1.53 %	K V
Geberit	508.00	-1.74 %	K V
Part Grp Hldg	1’386.00	-2.26 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Biocept Inc

Aktien Top/Flop

Meistgelesene Nachrichten